The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor

  • Maria Paola Ciliberti Department of Interdisciplinary Medicine, Section of Diagnostic Imaging and Radiotherapy, University Aldo Moro, Bari, Italy.
  • Rosa D'Agostino Department of Interdisciplinary Medicine, Section of Diagnostic Imaging and Radiotherapy, University Aldo Moro, Bari, Italy. https://orcid.org/0000-0001-9340-3316
  • Laura Gabrieli | gabrielilaura@gmail.com Department of Interdisciplinary Medicine, Section of Diagnostic Imaging and Radiotherapy, University Aldo Moro, Bari, Italy. http://orcid.org/0000-0001-6759-3937
  • Anna Nikolaou Department of Interdisciplinary Medicine, Section of Diagnostic Imaging and Radiotherapy, University Aldo Moro, Bari, Italy.
  • Angela Sardaro Department of Interdisciplinary Medicine, Section of Diagnostic Imaging and Radiotherapy, University Aldo Moro, Bari, Italy. https://orcid.org/0000-0002-3813-2709

Abstract

Hemangiopericytoma (HPC) is an extremely rare hypervascular tumor of mesenchymal lineage. It tends to recur and to develop distant metastases even many years after primary surgical resection. The management of recurrent and metastatic disease is not always so well defined. A complete surgical resection does not eliminate the high risk of local recurrences that occur in the central nervous system, often in the same surgical bed. However, treatment with adjuvant radiotherapy even in cases of complete resection remains controversial. Because of its rarity, there is no standard for treatment. We focused on radiotherapy treatment options, analyzing the literature and making a base on conduct further studies to establish the standard radiation dose to be used for locoregional control of such a complex and extremely rare disease and to help specialists to take the most appropriate therapeutic option.

Downloads

Download data is not yet available.

References

Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes. Ann Surg. 1942 Jul;116(1):26-33)

D'Amore ES, Manivel JC, Sung JH. Soft-tissue and meningeal hemangiopericytomas: an immunoh- istochemical and ultrastructural study. Hum Pathol 1990; 21:414-423

Begg CF, Garret R. Hemangiopericytoma occurring in the meninges: case report. Cancer. 1954; 7: 602-606)

(Paul Kleihues, Peter C. Burger and Bernd W. Scheithauer The New WHO Classification of Brain Tumours, Brain Pathology, Volume 3, Issue 3, pages 255–268, July 1993)

(Coffey RJ, Cascino TL, Shaw EG. Radiosurgical treatment of recurrent hemangiopericytomas of the meninges: preliminary results. J Neurosurg. 1993; 78: 903-908

Joseph JT, Lisle DK, Jacoby LB, Paulus W, Barone R, Cohen ML, et al. NF2 gene analysis distinguishes hemangiopericytoma from meningioma. Am J Pathol. 1995; 147: 1450-1455

Mena H, Ribas JL, Pezeshkpour GH, Cowan DN, Parisi JE . Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol. 1991; 22: 84-91

Ramsey HJ . Fine structure of hemangiopericytoma and hemangio- endothelioma. Cancer. 1966; 19: 2005-2018

Schiariti M, Goetz P, El-Maghraby H, Tailor J, Kitchen N. Hemangiopericytoma: long-term outcome revisited. Clinical article. J Neurosurg. 2011; 114: 747- 755

(Neurol Med Chir (Tokyo). 2006 Feb;46(2):92-7. Meningeal hemangiopericytoma manifesting as massive intracranial hemorrhage--two case reports. Maruya J(1), Seki Y, Morita K, Nishimaki K, Minakawa T.)

(Case Rep Neurol Med. 2014;2014:230681. Unpredicted Sudden Death due to Recurrent Infratentorial Hemangiopericytoma Presenting as Massive Intratumoral Hemorrhage: A Case Report and Review of the Literature. Tanaka T(1), Kato N(1), Hasegawa Y(1), Murayama Y(2))

(Oncol Lett. 2014 Nov;8(5):2140-2144. Epub 2014 Sep 4. Magnetic resonance imaging of intracranial hemangiopericytoma and correlation with pathological findings. Ma C(1), Xu F(2), Xiao YD(1), Paudel R(1), Sun Y(3), Xiao EH(1)

[Chiechi MV, Smirniotopoulos JG, Mena H. Intracranial hemangiopericytoma: MR and CT features. Am J Neuroradiol 1996;17:1365–71]

(Onco Targets Ther. 2015 Aug 20;8:2169-78.

Morphologic patterns and imaging features of intracranial hemangiopericytomas: a retrospective analysis. Pang H, Yao Z, Ren Y, Liu G, Zhang J, Feng X)

(Br J Radiol. 2010 Aug;83(992):e172-4. 18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases. Chan WS(1), Zhang J, Khong PL.)

Clin Nucl Med. 2014 May;39(5):478-9, (11) C-acetate PET/CT in a case of recurrent hemangiopericytom, Jong I(1), Chen S, Leung YL, Cheung SK, Ho CL

Kota G, Gupta P, Lesser GJ, Wilson JA, Mintz A. Somatostatin receptor molecular imaging for metastatic intracranial hemangiopericytoma. Clin Nucl Med. 2013 Dec;38(12):984-7

Abdollahi A(1), Abdollahpouri R(1), Tavangar SM(1). Meningeal Hemangiopericytoma in 33-Year-Old Female; a Case Report. Iran J Pathol. 2016 Summer;11(3):281-285

Asian Pac J Cancer Prev. 2015;16(16):6871-6.

Meningeal Hemangiopericytomas and Meningomas: a Comparative Immunohistochemical and Genetic Study.

Trabelsi S(1), Mama N, Chourabi M, Mastouri MH, Ladib M, Popov S, Burford A,

Mokni M, Tlili K, Krifa H, Jones C, Yacoubi MT, Saad A, Brahim DH

Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T, et al. Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer. 2012; 118: 1628-1636

Guthrie BL, Ebersold MJ, Scheithauer BW, Shaw EG. Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery. 1989;25:514–522

Jaaskelainen J, Servo A, Halta M, Wahlstrom T, Valtonen S. Intracranial hemangiopericytoma: radiology, surgery, radiotherapy, and outcome in 21 patients. Surg Neurol. 1985;23: 227–236

Suzuki H, Haga Y, Oguro K, Shinoda S, Masuzawa T, Kanai N. Intracranial hemangiopericytoma with extracranial metastasis occurring after 22 years. Neurol Med Chir (Tokyo). 2002 Jul;42(7):297-300)

Fusco MR, Salem MM, Gross BA, Reddy AS, Ogilvy CS, Kasper EM, Thomas AJ.

Preoperative Embolization of Extra-axial Hypervascular Tumors with Onyx. J Cerebrovasc Endovasc Neurosurg. 2016 Mar;18(1):12-8

Schmalbach CE, Gourin C. Managing Vascular Tumors-Open Approaches. Otolaryngol Clin North Am. 2016 Jun;49(3):777-90, Interv Neuroradiol. 2013 Dec;19(4):466-70. Epub 2013 Dec 18. Onyx embolization of an intracranial hemangiopericytoma by direct transcranial puncture. Ding D(1), Kreitel D, Liu KC.)

(Someya M, Sakata KL, Oouchi A, Nagakura H, Satoh M, Hareyama M. Four cases of meningeal hemangiopericytoma treated with surgery and radiotherapy. Jpn J Clin Oncol 2001;31:548–52

Carella RJ, Ransohoff J, Newall J : Role of radiation therapy in the man- agement of meningioma. Neurosurgery 10 : 332-339, 1982

Uemura S, Kuratsu J, Hamada J, Yoshioka S, Kochi M, Ushio Y, et al. : Effect of radiation therapy against intracranial hemangiopericytoma. Neurol Med Chir (Tokyo) 32 : 328-332, 1992 )

(Brain Tumor Res Treat. 2015 Oct;3(2):68-74. Treatment Strategy of Intracranial Hemangiopericytoma. Kim YJ, Park JH, Kim YI, Jeun SS)

Alén JF, Lobato RD, Gómez PA, Boto GR, Lagares A, Ramos A, et al. Intracranial hemangiopericytoma: study of 12 cases. Acta Neurochir (Wien). 2001; 143: 575-586

J Korean Neurosurg Soc. 2015 Sep;58(3):211-6. Intracranial Hemangiopericytomas : A Retrospective Study of 15 Patients with a Special Review of Recurrence. Noh SH, Lim JJ, Cho KG

Lal H, Sanyal B, Pant GC, Rastogi BL, Khanna NN, Udupa KN : Heman- giopericytoma : report of three cases regarding role of radiation therapy. AJR Am J Roentgenol 126 : 887-891, 1976

J Korean Neurosurg Soc 54 : 309-316, 2013, Clinical Analysis of Intracranial Hemangiopericytoma, Byoung-Joo Park, Young-Il Kim,Yong-Kil Hong, Sin-Soo Jeun, Kwan-Sung Lee, Youn-Soo Lee)

J Neurooncol. 2016 Mar;127(1):181-90. doi: 10.1007/s11060-015-2030-8. Epub 2015 Dec 31. The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma Lee EJ(1), Kim JH(2), Park ES(3), Khang SK(4), Cho YH(1), Hong SH(1), Kim CJ(1)

Melone AG, D'Elia A, Santoro F, Salvati M, Delfini R, Cantore G, Santoro A. Intracranial hemangiopericytoma--our experience in 30 years: a series of 43 cases and review of the literature. World Neurosurg. 2014 Mar-Apr;81(3-4):556-62

Dufour H, Metellus P, Fuentes S, Murracciole X, Regis J, Figarella-Branger D, et al. Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery. 2001; 48: 756-763

Fountas KN, Kapsalaki E, Kassam M, Feltes CH, Dimopoulos VG, Robinson JS, et al. Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev. 2006; 29: 145-153)

(Cancer. 2005 Dec 1;104(11):2457-65. Precision radiotherapy for hemangiopericytomas of the central nervous system. Combs SE(1), Thilmann C, Debus J, Schulz-Ertner D.)

Spina A, Boari N, Gagliardi F, Donofrio CA, Franzin A, Mortini P. The current role of Gamma Knife radiosurgery in the management of intracranial haemangiopericytoma. Acta Neurochir (Wien). 2016 Apr;158(4):635-42

(Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG. Management of recurrent meningeal hemangiopericytoma. Cancer 1998; 82:1915-1920)

Andrew B. Adegbite, Moe I. Khan, Kenneth W. E. Paine, Leonard K. Tan,The recurrence of intracranial meningiomas after surgical treatment, Journal of Neurosurgery, January 1983 / Vol. 58 / No. 1 : Pages 51-56

(Sheehan J, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for treatment of recurrent intracranial hemangiopericytomas. Neurosurgery 2002; 51: 905-911)

Ghose A, Guha G, Kundu R, Tew J, Chaudhary R. CNS Hemangiopericytoma: A

Systematic Review of 523 Patients. Am J Clin Oncol. 2014 Oct 27. [Epub ahead of

print] PubMed PMID: 25350465

[Brunori A, Delitala A, Oddi G, Chiappetta F. Recent experience in the management of meningeal hemangiopericytomas. Tumori 1997;83:856–61]

Chin Med J (Engl). 2006 Jan 20;119(2):169-73. Recurrent intracranial hemangiopericytoma with multiple metastases. Cao Y (1), Zhang MZ, Wang JM, Zhang W, Li G, Zhao JZ.)

[Bastin KT, Mehta MP. Meningeal hemangiopericytoma: defining the role for radiation therapy. J Neu- rooncol 1992;14:277–87)

(Koyama H, Harada A, Nakao A, et al. Intracranial hemangiopericytoma with metastasis to the pan- creas. Case report and literature review. J Clin Gas- troenterol 1997;25:706–8)

(Surg Neurol. 2003 Jan;59(1):47-53; discussion 53-4. Meningeal hemangiopericytomas: long-term outcome and biological behavior. Kim JH(1), Jung HW, Kim YS, Kim CJ, Hwang SK, Paek SH, Kim DG, Kwun BD)

[Goellner JR, Laws ER Jr, Soule EH, Okazaki H. Hemangiopericytoma of the meninges. Mayo Clinic Experi- ence. Am J Clin Pathol 1978;70:375–80)

Beadle GF, Hillcoat BL . Treatment of advanced malignant hemangiopericytoma with combination adriamycin and DTIC: a report of four cases. J Surg Oncol. 1983; 22: 167-170

Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011; 117: 4939- 4947).

Asian Pac J Cancer Prev. 2015;16(16):6871-6. Meningeal Hemangiopericytomas and Meningomas: a Comparative Immunohistochemical and Genetic Study. Trabelsi S(1), Mama N, Chourabi M, Mastouri MH, Ladib M, Popov S, Burford A, Mokni M, Tlili K, Krifa H, Jones C, Yacoubi MT, Saad A, Brahim DH.

Schweizer L, Koelsche C, Sahm F, Piro RM, Capper D, Reuss DE, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2- STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013; 125: 651-658]

(Delgado M, Pérez-Ruiz E, Alcalde J, Pérez D, Villatoro R, Rueda A . Anti-angiogenic treatment (sunitinib) for disseminated malignant haemangiopericytoma: a case study and review of the literature. Case Rep Oncol. 2011; 4: 55-59.

Kirn DH, Kramer A . Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytoma. J Natl Cancer Inst. 1996; 88: 764-765

Domont J, Massard C, Lassau N, Armand JP, Le Cesne A, Soria JC. Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haeman-gioperyctoma/solitary fibrous tumour. Invest New Drugs. 2010: 28: 199-202

Rossi G, Schirosi L, Giovanardi F, Sartori G, Paci M, Cavazza A . Pleural malignant solitary fibrous tumor with sarcomatous overgrowth showing PDGFRbeta mutation. Chest. 2006; 130: 581-583.

De Pas T, Toffalorio F, Colombo P, Trifiro G, Pelosi G, Vigna PD, et al. Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura. J Thorac Oncol. 2008; 3: 938–941.

(Staples JJ, Robinson RA, Wen BC, Hussey DH. Hemangiopericytoma--the role of radiotherapy. Int J Radiat Oncol Biol Phys. 1990 Aug;19(2): 445-51).

FRIEDMAN M, EGAN JW. Irradiation of hemangiopericytoma of Stout. Radiology. 1960 May;74:721-30

(Sakata K, Aoki Y, Tago M, Karasawa K, Nakagawa K, Hasezawa K, Muta N, Terahara A, Onogi Y, Sasaki Y, Hareyama M. Radiotherapy of bone metastases of a spinal meningeal hemangiopericytoma. Strahlenther Onkol. 1998 Apr;174(4):217-9).

Published
2018-07-10
Section
Reviews
Keywords:
Hemangiopericytoma, radiotherapy, bone metastases, vascular tumor, mesenchymal tumor.
Statistics
Abstract views: 560

PDF: 468
HTML: 107
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Ciliberti, M. P., D’Agostino, R., Gabrieli, L., Nikolaou, A., & Sardaro, A. (2018). The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor. Oncology Reviews, 12(2). https://doi.org/10.4081/oncol.2018.354

Most read articles by the same author(s)